3 days ago
Aquis lobster-pot listed Rutherford Health (RUTH) has announced yet another delay in its acquisition of Proton Partners International Health Care Investments LLC, UAE. The deal, originally announced on 31 August 2021 – along with a placing which is also delayed – was due to complete 21 days on from a share swap deed dated 28 August. Then it was 11 October 2021. Now it is 16 November and the ShareProphets bookies are offering generous odds on yet another extension after that.
13 days ago
Back in early August I observed that there were ‘continuing issues’ at Hargreaves Lansdown (HL.) which made me avoid the shares. Obviously I still do not own any today and this morning’s update keeps me of the view that the company’s shares are still stuck in a 1400-1800p range.
23 days ago
An email went out yesterday to those folks who have signed up with Harcus Parker to pursue Link over its Neil Woodford negligence. Marked Private & Confidential it is not to be forwarded to anybody. Thanks to Winnileaks I can publish it in full and do so below. It explains why the approach of Leigh Day is costly and wrong and what will happen next.
30 days ago
Itaconix (ITX) “is pleased to announce its unaudited interim results for the six months ended 30 June 2021”. The shares have responded currently approaching 7% lower to 8.3p. So “a leading innovator in plant-based specialty polymers” or still another Woodford pick dog?…
32 days ago
The top non-Tom article this week is Union Jack Oil – I have lost faith by Peter Brailey at number 2 or number 7 if you include the Bearcast.
33 days ago
I commented on Tuesday that Acquis-listed Rutherford Health (RUTH) seems to be having a bit of a problem collecting the placing proceeds originally announced at the end of August. The original payment day – September 13th – came and went, with an after-hours announcement that the deadline had been extended to September 23rd – yesterday. There was no announcement yesterday, but at 11.57am – ie lunchtime – today the company announced the grisly news:
37 days ago
This website has made no secret of its cynical take on the valuation of one of Neil Woodford’s most controversial investments into Acquis lobster-pot listed Rutherford Health (RUTH), formerly Proton Parters. There was a tiny investment made at its IPO allowing Woodford to mark up his original investment heavily, but since Woodford held all the cards apart from Rutherford’s management, there was nobody to sell and thus the apparent price was, we argued, totally illusory. We predicted problems when the cash ran out……
38 days ago
Today was Joshua’s birthday party so I am pretty whacked. In the podcast I look at how we fail to tackle financial crime – just 67 arrests by the dedicated unit responsible in H1. Then to ShareSoc. Will it on Wednesday blow off Jeff Prestridge as he blew off Neil Woodford? Or will it face him down and put one of the main enablers of what went on via his yellow journalism on the spot? I suggest some questions that Cliff Weight needs to put to Mr Presstrip. Or what abut listener Steve, would such an online showdown cheer you up?
42 days ago
It was back in December 2018 that Nigel mentioned ‘Neil Woodford raising more much-needed cash by dumping good shares’ by selling his stake in Kier Group (KIE), ‘a British construction, services and property group active in building and civil engineering, support services, and the Private Finance Initiative’. I am sure there were a bunch of reasons why Woodford needed the cash at the time, but this decision was not a complete disaster as the shares have fallen over 80% since. If only he could have missed all his other big losing calls! I have not been a great fan of Kier Group and related companies for many years, having seen plenty of sector ‘excitement’ over the past twenty-five years. Suffice to say there were a bunch of reasons why in an industry that can easily be impacted by economic volatility and too much debt.
50 days ago
Tissue Regenix (TRX) has announced results for the first half of 2021 claiming “we have created a commercially focussed regenerative global medtech company in a high growth sector… encouraged by our strong H1 results” and that we “look forward to this being further built on in H2”. So why are the shares, at 0.675p, currently more than 4% lower?
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen